Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
J Exp Med (1993) 177 (4): 1047–1060.
Currently there are no citedby results. Try again later.
